Strata Critical Medical (SRTA) Treasury Shares (2021 - 2026)

Strata Critical Medical (SRTA) has 6 years of Treasury Shares data on file, last reported at $13.6 million in Q1 2026.

• Quarterly Treasury Shares rose 24.61% year-over-year to $13.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $13.6 million (up 24.61% YoY) and the FY2025 annual result came in at $9.7 million, up 4.95% from the prior year.
• Treasury Shares improved to $13.6 million in Q1 2026 per SRTA's latest filing, from $9.7 million in the prior quarter.
• Across five years, Treasury Shares topped out at $13.6 million in Q1 2026 and bottomed at $2.4 million in Q3 2022.
• The 5-year median for Treasury Shares is $9.3 million (2024), against an average of $8.1 million.
• The widest annual swing landed in 2022, when Treasury Shares jumped 243.54%; it then retreated 29.55% in 2023.
• Tracing SRTA's Treasury Shares over 5 years: stood at $7.5 million in 2022, then declined by 29.55% to $5.3 million in 2023, then surged by 76.54% to $9.3 million in 2024, then grew by 4.95% to $9.7 million in 2025, then jumped by 39.11% to $13.6 million in 2026.
• Per Business Quant, the three latest SRTA Treasury Shares figures stand at $13.6 million (Q1 2026), $9.7 million (Q4 2025), and $10.4 million (Q3 2025).

Peer Comparison